APA

Litière S., Werutsky G., Fentiman I. S., Rutgers E., Christiaens M., Van Limbergen E., Baaijens M. H. A., Bogaerts J. & Bartelink H. (20120622). Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. : The Lancet. Oncology.

Chicago

Litière Saskia, Werutsky Gustavo, Fentiman Ian S, Rutgers Emiel, Christiaens Marie-Rose, Van Limbergen Erik, Baaijens Margreet H A, Bogaerts Jan and Bartelink Harry. 20120622. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. : The Lancet. Oncology.

Harvard

Litière S., Werutsky G., Fentiman I. S., Rutgers E., Christiaens M., Van Limbergen E., Baaijens M. H. A., Bogaerts J. and Bartelink H. (20120622). Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. : The Lancet. Oncology.

MLA

Litière Saskia, Werutsky Gustavo, Fentiman Ian S, Rutgers Emiel, Christiaens Marie-Rose, Van Limbergen Erik, Baaijens Margreet H A, Bogaerts Jan and Bartelink Harry. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. : The Lancet. Oncology. 20120622.